The ROE as of November 2024 (TTM) for Aligos Therapeutics, Inc. (ALGS) is -110.59%

According to Aligos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -110.59%. This represents a change of 288.13% compared to the average of -28.49% of the last 4 quarters.

Aligos Therapeutics, Inc. (ALGS) Historical ROE (quarterly & annually)

How has ALGS ROE performed in the past?

The mean historical ROE of Aligos Therapeutics, Inc. over the last ten years is -20.76%. The current -110.59% ROE has changed 432.66% with respect to the historical average. Over the past ten years (40 quarters), ALGS's ROE was at its highest in in the December 2019 quarter at 28.02%. The ROE was at its lowest in in the March 2024 quarter at -58.30%.

Aligos Therapeutics, Inc. (ALGS) ROE by Quarter and Year

Discovering the peaks and valleys of Aligos Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aligos Therapeutics, Inc. (ALGS) Average ROE

How has ALGS ROE performed in the past?

The current ROE of Aligos Therapeutics, Inc. (ALGS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aligos Therapeutics, Inc. (ALGS) ROE vs. Peers

How is ALGS’s ROE compared to its peers?

Aligos Therapeutics, Inc.’s ROE is greater than CytomX Therapeutics, Inc. (-27.44%), less than Spero Therapeutics, Inc. (20.70%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than Instil Bio, Inc. (-55.57%), greater than NextCure, Inc. (-57.63%), greater than Assembly Biosciences, Inc. (-121.55%), greater than Achilles Therapeutics plc (-47.36%), greater than Nuvation Bio Inc. (-98.79%),

Build a custom stock screener for Aligos Therapeutics, Inc. (ALGS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aligos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aligos Therapeutics, Inc. (ALGS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aligos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.